Tracking non-relapse mortality after CAR T cell therapy

被引：0
|
作者：
Blumenberg, Viktoria [1 ,2 ]
Maus, Marcela V. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
NATURE MEDICINE | 2024年 / 30卷 / 09期
关键词：
LYMPHOMA;
D O I：
10.1038/s41591-024-03212-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Infections account for the highest number of non-relapse-related deaths after CAR T cell therapy, underscoring the necessity for clinical risk-mitigating strategies and a deeper understanding of CAR T cell-related cytopenia.
引用
收藏
页码：2413 / 2414
页数：2
相关论文
共 50 条
  • [31] It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
    Luft, Thomas
    Benner, Axel
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer F.
    Gooley, Ted A.
    Sandmaier, Brenda M.
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Penack, Olaf
    BLOOD, 2016, 128 (22)
  • [32] Non-Relapse Mortality and Quality of Life with Shared Care after Allogeneic Hematopoietic Cell Transplantation: A Randomized Control Trial
    Abel, Gregory A.
    Kim, Haesook T.
    Zackon, Ira
    Alyea, Edwin P., III
    Bailey, Alexandra
    Winters, John P.
    Meehan, Kenneth R.
    Reagan, John L.
    Walsh, Jeanna
    Faggen, Meredith
    Sinclair, Sarah
    Joyce, Amy
    Close, Sara
    Emmert, Amy
    Kallassy, Isabella
    Koreth, John
    Antin, Joseph H.
    Cutler, Corey
    Ho, Vincent T.
    Soiffer, Robert J.
    BLOOD, 2022, 140 : 2135 - 2136
  • [33] Prior CD19-Targeted Therapy is Associated with Increased Non-Response and Relapse after CAR T Cell Therapy
    Pillai, V.
    Muralidharan, K.
    Rosenthal, J.
    Wertheim, G.
    Paessler, M.
    Maude, S.
    Grupp, S.
    Rheingold, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S54 - S55
  • [34] PRE-TRANSPLANT PULMONARY FUNCTION AND DAY 100 NON-RELAPSE MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Basa, S. K.
    Liesveld, J. L.
    Trawick, D. R.
    Fernandez, D.
    Nichols, D.
    Fisher, S. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 54 - 54
  • [35] Hematopoietic cell transplantation-specific comorbidity index to predict non-relapse mortality and survival after allografting.
    Kato, R
    Fukuda, T
    Usui, E
    Yamasaki, S
    Maruyama, D
    Morita, Y
    Kim, SW
    Mori, SI
    Tanosaki, R
    Tajima, K
    Heike, Y
    Makimoto, A
    Tobinai, K
    Takaue, Y
    BLOOD, 2005, 106 (11) : 766A - 767A
  • [36] Impact of pretransplant co-morbidities on non-relapse mortality and quality of life after allogeneic haematopoietic cell transplantation
    Nakaya, A.
    Mori, T.
    Aisa, Y.
    Yamazaki, R.
    Mihara, A.
    Ikeda, Y.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S47 - S47
  • [37] Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis
    Dreger, Peter
    Schubert, Maria-Luisa
    Holtick, Udo
    Subklewe, Marion
    von Bastian, Tresckow
    Ayuk, Francis A.
    Wagner, Eva Maria
    Wulf, Gerald
    Marks, Reinhard
    Penack, Olaf
    Schnetzke, Ulf
    Koenecke, Christian
    Von Bonin, Malte
    Stelljes, Matthias
    Glass, Bertram
    Baldus, Claudia D.
    Vucinic, Vladan
    Mougiakakos, Dimitrios
    Topp, Max
    Wolff, Daniel
    Schroers, Roland
    Borchmann, Peter
    Rejeski, Kai
    Hanoun, Christine
    Lengerke, Claudia
    Thomas, Simone
    Beelen, Dietrich W.
    Kroeger, Nicolaus
    Bethge, Wolfgang A.
    BLOOD, 2021, 138
  • [38] THE VALIDATION OF SIMPLIFIED COMORBIDITY INDEX FOR PREDICTION OF NON-RELAPSE MORTALITY
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Je-Hwan
    Lee, Kyoo-Hyung
    Lee, Young-Shin
    Kang, Young-A
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Choi, Yunsuk
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 515 - 516
  • [39] EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide
    Jacopo Mariotti
    Filippo Magri
    Laura Giordano
    Chiara De Philippis
    Barbara Sarina
    Daniele Mannina
    Daniela Taurino
    Armando Santoro
    Stefania Bramanti
    Bone Marrow Transplantation, 2023, 58 : 247 - 256
  • [40] EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide
    Mariotti, Jacopo
    Magri, Filippo
    Giordano, Laura
    De Philippis, Chiara
    Sarina, Barbara
    Mannina, Daniele
    Taurino, Daniela
    Santoro, Armando
    Bramanti, Stefania
    BONE MARROW TRANSPLANTATION, 2023, 58 (03) : 247 - 256
12345